Cytokines, breast cancer stem cells (BCSCs) and chemoresistance
Abstract Chemotherapy resistance of breast cancer poses a great challenge to the survival of patients. During breast cancer treatment, the development of intrinsic and acquired drug resistance tends to further induce adverse prognosis, such as metastasis. In recent years, the progress of research on...
Main Authors: | Weilong Chen, Yuanyuan Qin, Suling Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-09-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40169-018-0205-6 |
Similar Items
-
Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance
by: Sònia Palomeras, et al.
Published: (2018-08-01) -
Targeting stem cells in the realm of drug-resistant breast cancer
by: Dey P, et al.
Published: (2019-03-01) -
Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment
by: Miriam Gaggianesi, et al.
Published: (2021-07-01) -
Editorial: The Role of Breast Cancer Stem Cells in Clinical Outcomes
by: Dayanidhi Raman, et al.
Published: (2020-03-01) -
Betavulgarin Isolated from Sugar Beet (<i>Beta vulgaris</i>) Suppresses Breast Cancer Stem Cells through Stat3 Signaling
by: Ren Liu, et al.
Published: (2020-06-01)